Dr Tejas Shah - Judicious Use of Oral Drugs in the Management of Diabetes
Dr Tejas Shah, MBBS, Diabetologist in Mumbai, member of MCI, advises judicial use of oral drugs for diabetes management. Each drug has its own role: metformin reduces insulin resistance; sulfonylurea increases insulin secretion; DPP-4 inhibitor increases incretin levels; acarbose and voglibose reduce postprandial glucose concentrations; SGLT2i reduces renal tubular glucose reabsorption.
Dr Swati Srivastav - New Drug Molecules for Preventing Secondary Diabetic Complications
Dr Swati Srivastav emphasizes on preventing diabetic complications using new drugs molecules such as combination of SGLT2 inhibitors and DPP4 inhibitors. In regard to the cardiovascular outcomes, SGLT2 inhibitors reduce hospitalization due to heart failure. DPP4 inhibitors lowers CVD risk and aid in weight loss. It can also be used safely in patients with chronic kidney disease.
Dr Swati Srivastav - Effective Medications for Patients With Chronic Kidney Disease
Dr Swati Srivastav, MD, Fellow in Diabetes, Trained in Endocrine Tech, and professor at SMS Medical College, Jaipur. She shares her view on medications that can be effectively used in patients with renal impairment. SGLT2 inhibitor is a good option for patients with GRF as low as 45 ml/min. There are also some DPP-4 inhibitors, such as linagliptin, that can also be used in such patients.
Dr Sujoy Ghosh - Gliptins Are Effective in Improving Glycaemic Control in Diabetic Patients
Dr Sujoy Ghosh (MBBS, DM-Endocrinology, FRCP, FACE, FICP) – Associate Prof. at Dept. of Endocrinology, Kolkata. He shares his view on the need to achieve good glycemic control in patients with Diabetes Mellitus. Gliptins can be a good option to improve glycaemic control. Verify trial shows that vildagliptin in combination with metformin is effective in diabetes treatment.
